BiotechTube
Home/BrainChild Bio/Michael Jensen, MD
MJ

Michael Jensen, MD

Founder, Chief Scientific Officer

BrainChild Bio

Therapeutic Areas

OncologyNeuroscienceRare Disease

BrainChild Bio Pipeline

DrugIndicationPhase
BCB-276Diffuse Intrinsic Pontine Glioma (DIPG) in children/young adultsPivotal
BCB-214CNS Tumors (unspecified)Phase 1
BCB-513CNS Tumors (unspecified)Pre-clinical

Leadership Team at BrainChild Bio

SB
Steven Brugger
Chief Executive Officer
NA
Nicholas A. Vitanza, MD
Founding Chair, Scientific Advisory Board
View full BrainChild Bio profile